SolasCure publishes phase IIa clinical trial report in leading wound care journal Post author: Post published:March 4, 2024 Post category:uncategorized Study demonstrates proof-of-concept and strong safety profile of Aurase Wound Gel in patients suffering from chronic wounds. You Might Also Like MIT study reveals what happens inside the brain during sleep deprivation October 29, 2025 Driving sustainability through green technology: Cubic releases ESG 2024 report May 14, 2025 Yokogawa introduces CellVoyager High-Content Analysis System CQ3000 February 5, 2024